GHO Capital said to be finalizing acquisition of Alcaliber from Torreal and Sanofi Aventis
GHO Capital ultima la adquisición de Alcaliber a Torreal y Sanofi Aventis
Intel ID : 259671
|
Intel ID | 259671 | |||
Value | EUR 225,00m (Approx.) | |||
Native Currency | Euro (EUR) | |||
Date |
![]() |
|||
Country | ![]() |
|||
Region | ||||
Continent | ![]() |
|||
Geography | ![]() |
|||
Subsector (Old TTR Sectors) |
|
|||
Type |
![]() |
|||
Intel Grade |
![]() |
|||
Source |
![]() |
|||
Tags | ![]() |
Bidder
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Target
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Secondary Sectors (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Seller
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Seller
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
25.01.09 Private Equity 25 Financial Services / 25.01 Banking & Investment |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Financial Advisory
Parties | Advisor | Notes from Advisors | |||||
---|---|---|---|---|---|---|---|
|
|
- |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.